StockData
VolitionRx Ltd logo

VolitionRx Ltd (VNRX) stock

VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.20−0.03 (-13.13%)

Close on Nov 16, 2026Market cap $2.73MP/E –Yield –

VolitionRx gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for VolitionRx

VolitionRx has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More VolitionRx figures

See a number that looks wrong?